Slavic, Ksenija and Krishna, Sanjeev and Derbyshire, Elvira T and Staines, Henry M (2011) Plasmodial Sugar Transporters as Anti-malarial Drug Targets and Comparisons with Other Protozoa. Malaria Journal, 10. p. 165. ISSN 1475-2875 (FP7- 223044)
|
Text
223044-2011-165-Slavic.pdf - Published Version Download (3419Kb) | Preview |
Abstract
Glucose is the primary source of energy and a key substrate for most cells. Inhibition of cellular glucose uptake (the first step in its utilization) has, therefore, received attention as a potential therapeutic strategy to treat various unrelated diseases including malaria and cancers. For malaria, blood forms of parasites rely almost entirely on glycolysis for energy production and, without energy stores, they are dependent on the constant uptake of glucose. Plasmodium falciparum is the most dangerous human malarial parasite and its hexose transporter has been identified as being the major glucose transporter. In this review, recent progress regarding the validation and development of the P. falciparum hexose transporter as a drug target is described, highlighting the importance of robust target validation through both chemical and genetic methods. Therapeutic targeting potential of hexose transporters of other protozoan pathogens is also reviewed and discussed.
Funders
EUProjects
MALSIG; ANTIMAL (Grant No. 018834); Wellcome Trust (Grant No. 076441)Item Type: | Article |
---|---|
FP7 Grant Agreement Number: | 223044 |
FrameWork Programmes: | SP1-Cooperation |
Scientific Areas: | Health |
Contact Email Address: | kslavic@sgul.ac.uk |
Last Modified: | 26 Sep 2012 09:56 |
Access rights: | Open access |
Output type: | Article |
URI: | http://eprints.kobson.nb.rs/id/eprint/28 |
Actions (login required)
View Item |